-
1
-
-
0037268698
-
The quandary of compounding for MCOs: Administrative costs, risks, and waste
-
Kaye, T., The Quandary of Compounding for MCOs: Administrative Costs, Risks, and Waste, Managed Care 2003, 42.
-
(2003)
Managed Care
, pp. 42
-
-
Kaye, T.1
-
2
-
-
0034236714
-
Pharmacy compounding: Customizing prescription drugs
-
Nordenberg, T. Pharmacy Compounding: Customizing Prescription Drugs, FDA Consumer 2000, 11.
-
(2000)
FDA Consumer
, pp. 11
-
-
Nordenberg, T.1
-
3
-
-
0030017312
-
Regulatory and clinical aspects of the resurgence of compounding by pharmacists
-
Underbill, L. A.; Campbell, N. A.; Rhodes, C. T. Regulatory and clinical aspects of the resurgence of compounding by pharmacists, Drug Development and Industrial Pharmacy 1996, 22(7), 659.
-
(1996)
Drug Development and Industrial Pharmacy
, vol.22
, Issue.7
, pp. 659
-
-
Underbill, L.A.1
Campbell, N.A.2
Rhodes, C.T.3
-
4
-
-
33746362660
-
Pharmacy compounding and the FDA
-
Vivian, J.C., Pharmacy Compounding and the FDA, U.S. Pharmacist 2003, 28:01.
-
(2003)
U.S. Pharmacist
, vol.28
, pp. 01
-
-
Vivian, J.C.1
-
5
-
-
25144446551
-
Good compounding practices ⇒
-
USP Council of Experts Committee, eds. Good compounding practices ⇒, Pharmacopeial Forum 2002, 28, 640.
-
(2002)
Pharmacopeial Forum
, vol.28
, pp. 640
-
-
-
6
-
-
25144436650
-
Compounding and the Supreme Court
-
Vivian, J.C., Compounding and the Supreme Court, U.S. Pharmacist 2002, 27:07.
-
(2002)
U.S. Pharmacist
, vol.27
, pp. 07
-
-
Vivian, J.C.1
-
7
-
-
25144441946
-
Compounding paradox: Taught less and practiced more
-
Newton, D.W., Compounding Paradox: Taught Less and Practiced More, American Journal of Pharmaceutical Education 2003, 67(1),12.
-
(2003)
American Journal of Pharmaceutical Education
, vol.67
, Issue.1
, pp. 12
-
-
Newton, D.W.1
-
8
-
-
0032925395
-
Comments on drugs difficult to compound and the quality of chemicals to be used in compounding
-
Perrin, J. H. Comments on drugs difficult to compound and the quality of chemicals to be used in compounding, Drug Development and Industrial Pharmacy 1999, 25(4), 553.
-
(1999)
Drug Development and Industrial Pharmacy
, vol.25
, Issue.4
, pp. 553
-
-
Perrin, J.H.1
-
11
-
-
25144464718
-
Guidance for FDA staff and industry, pharmacy compounding
-
460.200
-
FDA, Guidance for FDA Staff and Industry, Pharmacy Compounding, Compliance Policy Guides Manual 2002, 460.200, 1.
-
(2002)
Compliance Policy Guides Manual
, pp. 1
-
-
-
13
-
-
84926233621
-
Termination of two food and Drug Administration Advisory Committees
-
Skladany, L. A. Termination of Two Food and Drug Administration Advisory Committees, Federal Register 2002, 67(225), 70227.
-
(2002)
Federal Register
, vol.67
, Issue.225
, pp. 70227
-
-
Skladany, L.A.1
-
14
-
-
25144436131
-
Compounding pharmacies offered seal of approval
-
Ukens, C., Compounding pharmacies offered seal of approval. Drug Topics 2004, 148, 34.
-
(2004)
Drug Topics
, vol.148
, pp. 34
-
-
Ukens, C.1
|